financetom
Business
financetom
/
Business
/
Synopsys Q4 Earnings: Revenue Beat, EPS Beat, Soft Guidance, Expanding Opportunities Powered By 'AI-Driven Reinvention Of Compute'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Synopsys Q4 Earnings: Revenue Beat, EPS Beat, Soft Guidance, Expanding Opportunities Powered By 'AI-Driven Reinvention Of Compute'
Dec 4, 2024 2:40 PM

Synopsys Inc ( SNPS ) reported fourth-quarter financial results after the market close on Wednesday. Here’s a rundown of the report.

Q4 Revenue: $1.64 billion, versus estimates of $1.63 billion

Q4 Adjusted EPS: $3.40, versus estimates of $3.30

“The fourth quarter was a strong finish to a transformational year for Synopsys ( SNPS ). We achieved record financial results while doubling down on our strategy with the sale of our Software Integrity business and the pending acquisition of Ansys,” said Sassine Ghazi, president and CEO of Synopsys ( SNPS ).

“Looking ahead, the AI-driven reinvention of compute is accelerating the pace, scale and complexity of technology R&D, which expands our opportunity to solve engineering challenges from silicon to systems.”

Synopsys ( SNPS ) said its previously announced acquisition of Ansys is expected to close in the first half of 2025. The company is working cooperatively with the Federal Trade Commission (FTC) to conclude the investigation and the staff’s review of Synopsys’ proposed remedies.

Outlook: Synopsys ( SNPS ) expects first-quarter revenue to be in the range of $1.435 billion to $1.465 billion versus estimates of $1.643 billion, according to Benzinga Pro. The company sees first-quarter adjusted earnings between $2.77 and $2.82 per share versus estimates of $3.53 per share.

Synopsys ( SNPS ) noted that its outlook reflects a change in the company’s fiscal year from a 52/53-week period ending on the Saturday nearest to Oct. 31 of each year to Oct. 31 of each year. As a result of this change, there will be 10 fewer days in the first half of fiscal year 2025.

“In 2025, we expect to deliver double-digit revenue growth grounded in pragmatism given continued macro uncertainties and the impact of our fiscal year calendar change,” said Shelagh Glaser, CFO of Synopsys ( SNPS ).

SNPS Price Action: Synopsys ( SNPS ) shares were down 6.23% in after-hours, trading at $551.37 at the time of publication Wednesday, per Benzinga Pro.

Read Next:

ChargePoint Stock Rallies After Q3 Results: EPS In Line, Revenues Beat

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved